查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439246

冠状动脉支架 - 全球市场回顾、竞争格局、市场预测2030

Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2023年全球冠状动脉支架市场规模将达到92.7亿美元，到2030年将达到142.8亿美元，2024-2030年预测期间内复合年增长率为7.51%。 冠状动脉支架需求的增加主要是由于人口老化的增加、PCI（经皮冠状动脉介入治疗）手术数量的增加，导致中风、动脉粥状硬化和心臟病等心血管疾病的盛行率不断增加，这这是由于对微创手术的需求增加、产品线的技术进步等。

冠状动脉支架市场动态

影响冠状动脉支架市场成长的主要因素之一是世界各地各种心血管疾病的盛行率不断增加。 例如，根据美国心臟协会（2022）的数据，2020 年全球约有 2.441 亿人患有冠状动脉心臟病（缺血性心臟病）。

根据英国心臟基金会（2022年）提供的数据，2019年冠心病仍是全球最常见的心血管疾病，全球约有2亿患者，其中就有一位。

以某种方式导致心血管疾病发展的危险因子（例如老龄、肥胖和吸烟）的增加进一步推动了冠状动脉支架市场的成长。 例如，根据世界卫生组织（2023）提供的数据，2020年全球60岁以上人口约为10亿。 预计到 2050 年，60 岁及以上的老年人口将增加一倍，达到约 21 亿人。

因此，透过使用冠状动脉支架进行适当的治疗可以控製或减少由于上述疾病而增加的发病率和死亡率，从而导致对该设备的需求增加。 因此，上述因素预计将在未来几年提振整个冠状动脉支架市场。

产品召回增加和严格的监管审批程序等某些因素可能会对冠状动脉支架市场的成长构成轻微障碍。

冠状动脉支架市场区隔分析

在冠状动脉支架产品领域，药物洗脱支架预计在预测期内占据最大的市场份额。 这是由于药物洗脱支架相对于裸金属支架等具有多种优点。

药物洗脱支架比裸金属支架更能有效预防再狭窄，且新一代药物洗脱支架的使用也降低了支架内血栓和心肌梗塞的发生率。 例如，研究表明，风险相对较低的患者群体中支架内血栓的 5 年发生率为 0.5%。

此外，最近的产品核准也有望进一步提振药物洗脱冠状动脉支架市场。 例如，2020年，SCITECH Medical第三代药物洗脱支架INSPIRON冠状动脉西罗莫司洗脱支架获得CE标誌核准。

因此，上述因素可能会推动冠状动脉支架市场的细分成长。

北美预计将主导整个冠状动脉支架市场。

在所有国家中，预计北美在预测期内将主导整个冠状动脉支架市场。 这一优势得益于冠心病和其他心血管疾病患病率的上升、医疗基础设施的改善以及有利的报销方案。

美国疾病管制与预防中心 (CDC) (2022) 估计，2020 年美国将有约 2,010 万名 20 岁以上成年人患有冠状动脉疾病 (CAD)。 此外，根据同一消息来源，美国每 40 秒就有一人心臟病发作。 美国每年约有 805,000 人心臟病发作。 其中，605,000 人首次心臟病发作，20 万人已发作心臟病。

本报告研究和分析了全球冠状动脉支架市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第一章冠状动脉支架市场报告简介

第二章冠状动脉支架市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估

第三章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章冠状动脉支架市场主要因素分析

  • 冠状动脉支架市场驱动因素
    • 心血管疾病 (CVD) 盛行率不断上升
    • PCI（经皮冠状动脉介入治疗）手术数量增加
    • 对微创手术的需求不断增加
    • 技术进步
  • 冠状动脉支架市场的限制与挑战
    • 产品召回
    • 严格的监管审批
  • 冠状动脉支架市场机遇
    • 转向生物可吸收血管支架
    • 新兴国家的成长机会

第五章冠状动脉支架的波特五力分析

第六章冠状动脉支架市场布局

  • 依产品类型
    • 裸金属支架
    • 药物洗脱支架
    • 药物涂层支架
  • 依材质
    • 金属
    • 聚合物
  • 按最终用户
    • 医院
    • 门诊手术中心
    • 其他
  • 按地区
    • 北美冠状动脉支架市场规模（2021-2030）
    • 欧洲冠状动脉支架市场规模（2021-2030）
    • 亚太地区冠状动脉支架市场规模（2021-2030）
    • 其他地区冠状动脉支架市场规模（2021-2030年）

第七章冠状动脉支架公司及产品简介

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Biosensors International Group, Ltd.
  • BIOTRONIK
  • B. Braun Melsungen AG
  • Terumo Corporation
  • STENTYS SA
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Vascular Concepts
  • COOK
  • SCITECH Medical
  • Lepu Medical Technology Co., Ltd.
  • OrbusNeich Medical Company Limited

第8章KOL浏览量

第 9 章专案方法

第10章DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明与联络我们

Product Code: DIMDCL0033

The global coronary stents market was valued at USD 9.27 billion in 2023, growing at a CAGR of 7.51% during the forecast period from 2024 to 2030, to reach USD 14.28 billion by 2030. The rise in demand for coronary stents is primarily attributed to the rising prevalence of cardiovascular disorders such as stroke, atherosclerosis, and heart attack due to the increasing geriatric population; a growing number of PCI (Percutaneous Coronary Intervention) procedures; increase in demand for minimally invasive surgeries, and technological advancement in the product line, among others.

Coronary Stents Market Dynamics:

One of the key factors influencing the growth of the coronary stents market is the increasing prevalence of various cardiovascular diseases across the globe. For instance, according to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020.

As per the data provided by British Heart Foundation 2022, in 2019 coronary heart disease remained one of the most prevalent cardiovascular conditions worldwide accounting for about 200 million cases globally.

The increasing number of risk factors such as old age, obesity, smoking, and others causing the development of cardiovascular diseases in one or another way are further driving the market growth for coronary stents. For instance, according to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050.

Thus, the increasing prevalence and mortality rate from the above-mentioned disorders can be either managed or reduced by providing proper treatment using coronary stents, thereby leading to an increased demand for the device. Therefore, the afore-said factor will propel the overall market of coronary stents in the upcoming years.

Certain factors such as increasing product recalls, and stringent regulatory approval processes may pose a minor hurdle to the growth of the coronary stents market.

Coronary Stents Market Segment Analysis:

Coronary Stents By Product Type (Bare Metal Stents, Drug Eluting Stents, and Drug-Coated Stents), Material (Metals [Stainless Steel, Cobalt-Chromium (CoCr), Platinum-Chromium (PtCr), and Nitinol] and Polymers), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Coronary Stents product segment, the drug-eluting stent is expected to hold the largest market share during the forecast period. This is due to the various advantages of drug-eluting stents over bare metal stents and others.

Drug-eluting stents are more effective in the prevention of restenosis than the use of bare-metal stents, the use of newer-generation drug-eluting stents also reduces the rate of stent thrombosis and myocardial infarction. For instance, as per research studies, there was a 0.5% rate of stent thrombosis at 5 years among a relatively low-risk population of patients.

Moreover, recent product approval is also anticipated to further boost the market the drug-eluting coronary stent market. For instance, in 2020, SCITECH Medical received CE Mark approval for its third-generation drug-eluting stent, INSPIRON Coronary Sirolimus Eluting Stent.

Therefore, the aforementioned factors are likely to propel the segmental growth of the coronary stents market.

North America is expected to dominate the overall Coronary Stents Market:

Among all the countries, North America is expected to dominate the overall coronary stents market during the forecast period. This domination is due to the rising prevalence of coronary heart diseases and other CVDs, improved healthcare infrastructure, and favorable reimbursement scenarios in the region among others.

The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020. Also, the same source stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent-the damage is done, but the person is not aware of it.

In addition, the presence of key manufacturers such as Medtronic, and Boston Scientific Corporation, among others is also likely to boost the coronary stents market. Furthermore, recent product approval in the region will also contribute to the market growth. For instance, in 2019, German medical device company Biotronik received US Food and Drug Administration (FDA) approval for Orsiro drug-eluting coronary stent (DES) system.

Hence, the above-mentioned factors are contributing in regional market growth during the forecast period.

Coronary Stents Market Key Players:

Some of the key market players operating in the coronary stents market include Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.

Coronary Stents Market Recent Developmental Activities:

In August 2020, Boston Scientific Corporation received FDA approval for its SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail and Over-The-Wire).

In October 2020, Biosensors received the CE Mark for BioFreedomUltra, a new drug-coated coronary stent system with a thin strut (84µm) CoCr polymer and Biosensors' Biolimus A9 drug.

Key Takes Away from the Coronary Stents Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global coronary stents market.

Various opportunities available for the other competitor in the coronary stents market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for coronary stents market growth in the coming future?

Target Audience who can be benefited from Coronary Stents Market Report Study

Coronary Stents providers

Research organizations and consulting companies

Coronary Stents-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Coronary Stents

Various End-Users who want to know more about the coronary stents market and the latest technological developments in the coronary stents market.

Frequently Asked Questions for Coronary Stents Market:

1. What are Coronary Stents?

Coronary stents are small, expandable, wired mesh tubes that help in the widening of a clogged artery and restore adequate blood flow to the heart. These stents are predominantly of two categories bare metal and drug-eluting.

2. What is the market for global coronary stents?

The global coronary stents market was valued at USD 9.27 billion in 2023, growing at a CAGR of 7.51% during the forecast period from 2024 to 2030, to reach USD 14.28 billion by 2030.

3. What are the drivers for global coronary stents?

The major drivers driving the demand for coronary stents are the growing burden of the old age population susceptible to various cardiovascular disorders, shifting preferences towards minimally invasive surgeries, and technological advancement in the product line, among others.

4. Who are the key players operating in global coronary stents?

Some of the key market players operating in the coronary stents market include Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.

5. Which region has the highest share in the coronary stents market?

North America is anticipated to dominate the overall coronary stents market during the forecast period, 2024-2030 due to the improved healthcare infrastructure, and favorable reimbursement scenario in the region. Moreover, recent product approvals and the presence of key manufacturers are also factors contributing to the highest market share.

Table of Contents

1. Coronary Stents Market Report Introduction

2. Coronary Stents Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Coronary Stents Market Key Factors Analysis

  • 4.1. Coronary Stents Market Drivers
    • 4.1.1. Rising prevalence of cardiovascular disorders (CVDs)
    • 4.1.2. Growing number of PCI (Percutaneous Coronary Intervention) procedures
    • 4.1.3. Increasing demand for minimally invasive surgeries
    • 4.1.4. Technological advancements
  • 4.2. Coronary Stents Market Restraints and Challenges
    • 4.2.1. Product recalls
    • 4.2.2. Stringent regulatory approvals
  • 4.3. Coronary Stents Market Opportunities
    • 4.3.1. Shift toward bioresorbable vascular scaffolds
    • 4.3.2. Growth opportunities in emerging countries

5. Coronary Stents Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Coronary Stents Market layout

  • 6.1. By Product Type
    • 6.1.1. Bare Metal Stents
    • 6.1.2. Drug Eluting Stents
    • 6.1.3. Drug-Coated Stents
  • 6.2. By Material
    • 6.2.1. Metals
      • 6.2.1.1. Stainless Steel
      • 6.2.1.2. Cobalt-Chromium (CoCr)
      • 6.2.1.3. Platinum-Chromium (PtCr)
      • 6.2.1.4. Nitinol
    • 6.2.2. Polymers
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Coronary Stents Market Size in USD million (2021-2030)
    • 6.4.2. Europe Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.1. France Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Coronary Stents Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.1. China Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.3. India Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia Pacific Coronary Stents Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Coronary Stents Market Size in USD million (2021-2030)

7. Coronary Stents Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Abbott
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Boston Scientific Corporation
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Biosensors International Group, Ltd.
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. BIOTRONIK
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. B. Braun Melsungen AG
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Terumo Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. STENTYS SA
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. MicroPort Scientific Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Meril Life Sciences Pvt. Ltd.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Vascular Concepts
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. COOK
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. SCITECH Medical
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Lepu Medical Technology Co., Ltd.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. OrbusNeich Medical Company Limited
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Coronary Stents Market in Global (2021-2030)
  • Table 3: Coronary Stents Market in Global by Product Type (2021-2030)
  • Table 4: Coronary Stents Market in Global by Material (2021-2030)
  • Table 5: Coronary Stents Market in Global by End-User (2021-2030)
  • Table 6: Coronary Stents Market in Global by Geography (2021-2030)
  • Table 7: Coronary Stents Market in North America (2021-2030)
  • Table 8: Coronary Stents Market in the US (2021-2030)
  • Table 9: Coronary Stents Market in Canada (2021-2030)
  • Table 10: Coronary Stents Market in Mexico (2021-2030)
  • Table 11: Coronary Stents Market in Europe (2021-2030)
  • Table 12: Coronary Stents Market in France (2021-2030)
  • Table 13: Coronary Stents Market in Germany (2021-2030)
  • Table 14: Coronary Stents Market in the United Kingdom (2021-2030)
  • Table 15: Coronary Stents Market in Italy (2021-2030)
  • Table 16: Coronary Stents Market in Spain (2021-2030)
  • Table 17: Coronary Stents Market in Rest of Europe (2021-2030)
  • Table 18: Coronary Stents Market in Asia-Pacific (2021-2030)
  • Table 19: Coronary Stents Market in China (2021-2030)
  • Table 20: Coronary Stents Market in Japan (2021-2030)
  • Table 21: Coronary Stents Market in India (2021-2030)
  • Table 22: Coronary Stents Market in Australia (2021-2030)
  • Table 23: Coronary Stents Market in South Korea (2021-2030)
  • Table 24: Coronary Stents Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Coronary Stents Market in the Rest of the World (2021-2030)
  • Table 26: Coronary Stents Market in the Middle East (2021-2030)
  • Table 27: Coronary Stents Market in Africa (2021-2030)
  • Table 28: Coronary Stents Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Coronary Stents Market in Global (2021-2030)
  • Figure 3: Coronary Stents Market in Global by Product Type (2021-2030)
  • Figure 4: Coronary Stents Market in Global by Material (2021-2030)
  • Figure 5: Coronary Stents Market in Global by End-User (2021-2030)
  • Figure 6: Coronary Stents Market in Global by Geography (2021-2030)
  • Figure 7: Coronary Stents Market in North America (2021-2030)
  • Figure 8: Coronary Stents Market in the US (2021-2030)
  • Figure 9: Coronary Stents Market in Canada (2021-2030)
  • Figure 10: Coronary Stents Market in Mexico (2021-2030)
  • Figure 11: Coronary Stents Market in Europe (2021-2030)
  • Figure 12: Coronary Stents Market in France (2021-2030)
  • Figure 13: Coronary Stents Market in Germany (2021-2030)
  • Figure 14: Coronary Stents Market in the United Kingdom (2021-2030)
  • Figure 15: Coronary Stents Market in Italy (2021-2030)
  • Figure 16: Coronary Stents Market in Spain (2021-2030)
  • Figure 17: Coronary Stents Market in Rest of Europe (2021-2030)
  • Figure 18: Coronary Stents Market in Asia-Pacific (2021-2030)
  • Figure 19: Coronary Stents Market in China (2021-2030)
  • Figure 20: Coronary Stents Market in Japan (2021-2030)
  • Figure 11: Coronary Stents Market in India (2021-2030)
  • Figure 22: Coronary Stents Market in Australia (2021-2030)
  • Figure 23: Coronary Stents Market in South Korea (2021-2030)
  • Figure 24: Coronary Stents Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 25: Coronary Stents Market in the Rest of the World (2021-2030)
  • Figure 26: Coronary Stents Market in the Middle East (2021-2030)
  • Figure 27: Coronary Stents Market in Africa (2021-2030)
  • Figure 28: Coronary Stents Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER's Five Force Analysis